Rafael A. Medina Lopez
Rafael A. Medina Lopez
Profesor Asociado CIS Urología. Universidad Sevilla. H.U.Virgen del Rocio
Verified email at - Homepage
Cited by
Cited by
Darolutamide in nonmetastatic, castration-resistant prostate cancer
K Fizazi, N Shore, TL Tammela, A Ulys, E Vjaters, S Polyakov, M Jievaltas, ...
NEW ENGLAND JOURNAL OF MEDICINE (0028-4793 / 1533-4406) 380 (13), 1235-46, 2019
Nonmetastatic, castration-resistant prostate cancer and survival with darolutamide
K Fizazi, N Shore, TL Tammela, A Ulys, E Vjaters, S Polyakov, M Jievaltas, ...
NEW ENGLAND JOURNAL OF MEDICINE (0028-4793 / 1533-4406) 383 (11), 1040-49, 2020
Immunohistochemical expression of Hsp60 correlates with tumor progression and hormone resistance in prostate cancer
C Castilla, B Congregado, JM Conde, R Medina, FJ Torrubia, MÁ Japón, ...
UROLOGY (0090-4295 / 1527-9995) 76 (4), 1017, 2010
Quality of life in patients with lower urinary tract symptoms associated with BPH: change over time in real-life practice according to treatment—the QUALIPROST study
A Alcaraz, J Carballido-Rodríguez, M Unda-Urzaiz, R Medina-López, ...
International urology and nephrology 48 (5), 645-656, 2016
Bladder cancer in Spain 2011: population based study
B Miñana, JM Cózar, J Palou, M Unda Urzaiz, RA Medina-Lopez, ...
The Journal of urology 191 (2), 323-328, 2014
Gene expression test for the non-invasive diagnosis of bladder cancer: A prospective, blinded, international and multicenter validation study
MJ Ribal, L Mengual, JJ Lozano, M Ingelmo-Torres, J Palou, ...
European journal of cancer 54, 131-138, 2016
Mycotic pseudoaneurysm following a kidney transplant: a case report and review of the literature
I Osman, R Barrero, E León, R Medina, F Torrubia
PEDIATRIC TRANSPLANTATION (1397-3142 / 1399-3046) 13 (5), 615-19, 2009
Prostate cancer cell response to Paclitaxel is affected by abnormally expressed securin PTTG1
C Castilla, ML Flores, R Medina, B Pérez-Valderrama, F Romero, ...
MOLECULAR CANCER THERAPEUTICS (1535-7163 / 1538-8514) 13 (10), 2372-83, 2014
Castration-resistant metastatic prostate cancer: current status and treatment possibilities
J Carles, D Castellano, MÁ Climent, P Maroto, R Medina, A Alcaraz
CLINICAL & TRANSLATIONAL ONCOLOGY (1699-048X / 1699-3055) 14 (3), 169-76, 2012
PARP Inhibitors: A New Horizon for Patients with Prostate Cancer
B Congregado, I Rivero, I Osmán, C Sáez, R Medina López
Biomedicines 10 (6), 1416, 2022
Obatoclax and paclitaxel synergistically induce apoptosis and overcome paclitaxel resistance in urothelial cancer cells
R Jiménez-Guerrero, J Gasca, ML Flores, B Pérez-Valderrama, ...
CANCERS (2072-6694) 10 (12), 490, 2018
Radical prostatectomy after vascular targeted photodynamic therapy with padeliporfin: feasibility, and early and intermediate results
V Pierrard, S Lebdai, F Kleinclauss, AR Azzouzi, JE Terrier, E Fortier, ...
The Journal of Urology 201 (2), 315-321, 2019
Loss of PKCδ induces prostate cancer resistance to Paclitaxel through activation of Wnt/beta-catenin pathway and Mcl-1 accumulation
ML Flores, C Castilla, J Gasca, R Medina, B Pérez-Valderrama, F Romero, ...
MOLECULAR CANCER THERAPEUTICS (1535-7163 / 1538-8514) 15 (7), 1713-1725, 2016
Downregulation of protein tyrosine phosphatase PTPL1 alters cell cycle and upregulates invasion-related genes in prostate cancer cells
C Castilla, ML Flores, JM Conde, R Medina, FJ Torrubia, MÁ Japón, ...
CLINICAL & EXPERIMENTAL METASTASIS (0262-0898 / 1573-7276) 29 (4), 349-358, 2012
Measurement of urine pH for epidemiological studies on bladder cancer
J Alguacil, RM Pfeiffer, LE Moore, MR Del Fresno, R Medina-Lopez, ...
European journal of epidemiology, 91-98, 2007
PTPL1 and PKCδ contribute to proapoptotic signalling in prostate cancer cells
C Castilla, D Chinchón, R Medina, FJ Torrubia, MÁ Japón, C Sáez
CELL DEATH & DISEASE (2041-4889) 4, e576, 2013
Key areas in the learning curve for robotic urological surgery: a Spanish multicentre survey
Urologia Internationalis (0042-1138 / 1423-0399) 87 (1), 64-69, 2011
Prospective study of diagnostic accuracy in the detection of high‐grade prostate cancer in biopsy‐naïve patients with clinical suspicion of prostate cancer who underwent the …
G Lendínez‐Cano, AV Ojeda‐Claro, E Gómez‐Gómez, ...
The Prostate 81 (12), 857-865, 2021
Clinical benefit of tamsulosin and the hexanic extract of Serenoa repens, in combination or as monotherapy, in patients with moderate/severe LUTS-BPH: a subset analysis of the …
A Alcaraz, A Rodríguez-Antolín, J Carballido-Rodríguez, D Castro-Díaz, ...
Journal of clinical medicine 9 (9), 2909, 2020
Cáncer de próstata resistente a castración:¿ hacia dónde vamos?
A Alcaraz, R Medina, P Maroto, MA Climent, D Castellano, J Carles
Actas Urológicas Españolas 36 (6), 367-374, 2012
The system can't perform the operation now. Try again later.
Articles 1–20